Total Funding
57
56
Total FundingSeed raised
Growth Score 57 in past quarter
-32 pts
Heat Score 56 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
112763
IDBiologics is a human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.
- Charles Haines: Co-Founder & CEO
- James Crowe: Co-Founder
About the Company
IDBiologics was founded in 2017 to discover and develop human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.Their innovative fully human monoclonal antibody platform enables rapid discovery and optimization of broad and potent therapeutic molecules.Using this proprietary platform, IDBiologics has accumulated
unparalleled breadth in isolating antibodies for infectious diseases, with lead candidate molecules to diverse targets moving forward in development.